A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome

NCT00658515 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

15871

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Heart Disease

Interventions

DRUG: Dalcetrapib (RO4607381)
DRUG: Evidence-based medical care for Acute Coronary Syndrome
DRUG: Placebo

Sponsor

Hoffmann-La Roche